Pfizer Nabs Booster OK In U.S. — But How Long Will It Hold The Covid Lead?

Pfizer Nabs Booster OK In U.S. — But How Long Will It Hold The Covid Lead?·Investor's Business Daily
In this article:

Vaccine stocks popped Thursday after the FDA authorized Pfizer and BioNTech's Covid booster shot for at-risk groups.

Advertisement